Schering-Plough net falls 71% on weak sales by drug lineup
Article Abstract:
Schering-Plough Corp. posted a decline of 71% in its net profits for the 2003 first quarter. The company, which was hurt by weak drug sales, posted $173 million (149.9 million euros) in quarterly net profits.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Merck reports flat earnings in drug business
Article Abstract:
Merck and Co. posted flat pharmaceutical earnings for the 2003 first quarter. The company posted pharmaceutical earnings of $1.55 billion for the period, a less than 1% drop.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Schering-Plough gives warning on earnings
Article Abstract:
Schering-Plough Corp. forecasted a drop in net income for the 2003 year. The company said that its net income for 2003 could drop by over 64%.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The light fades: socialists dogged by old policies and tired leaders. Breaking out: can the Japan New Party succeed?
- Abstracts: How to fail the people. Chinese firm hits a glass ceiling in South Carolina. Strategic rivalries
- Abstracts: The dangers of jobless growth. Increasing doses in India
- Abstracts: Digging itself out of debt. Turning around. Strong performer
- Abstracts: Alstom net more than doubles as demand for power expands. EU gives strict ultimatum for France's Alstom rescue: bailout is contingent upon a commitment to future alliances